- Home
- OVID vs IPA Comparison
OVID vs IPA Comparison
Compare OVID & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- IPA
- Stock Information
- Founded
- OVID 2014
- IPA 1983
- Country
- OVID United States
- IPA United States
- Employees
- OVID N/A
- IPA N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- IPA Health Care
- Exchange
- OVID Nasdaq
- IPA Nasdaq
- Market Cap
- OVID 24.0M
- IPA 20.6M
- IPO Year
- OVID 2017
- IPA 2017
- Fundamental
- Price
- OVID $0.29
- IPA $0.45
- Analyst Decision
- OVID Strong Buy
- IPA Strong Buy
- Analyst Count
- OVID 6
- IPA 2
- Target Price
- OVID $3.03
- IPA $4.00
- AVG Volume (30 Days)
- OVID 376.8K
- IPA 407.1K
- Earning Date
- OVID 05-20-2025
- IPA 03-28-2025
- Dividend Yield
- OVID N/A
- IPA N/A
- EPS Growth
- OVID N/A
- IPA N/A
- EPS
- OVID N/A
- IPA N/A
- Revenue
- OVID $566,000.00
- IPA $16,581,105.00
- Revenue This Year
- OVID N/A
- IPA $4.67
- Revenue Next Year
- OVID $36.11
- IPA $14.15
- P/E Ratio
- OVID N/A
- IPA N/A
- Revenue Growth
- OVID 44.39
- IPA 1.34
- 52 Week Low
- OVID $0.24
- IPA $0.27
- 52 Week High
- OVID $3.43
- IPA $1.36
- Technical
- Relative Strength Index (RSI)
- OVID 39.90
- IPA 52.32
- Support Level
- OVID $0.28
- IPA $0.45
- Resistance Level
- OVID $0.33
- IPA $0.48
- Average True Range (ATR)
- OVID 0.03
- IPA 0.03
- MACD
- OVID 0.00
- IPA 0.00
- Stochastic Oscillator
- OVID 16.97
- IPA 55.57
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.